Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimises endocrine and sexual problems: A prospective study

Vermeulen, R.F.M.; Beurden, M. van; Kieffer, J.M.; Bleiker, E.M.A.; Valdimarsdottir, H.B.; Massuger, L.F.A.G.; ... ; Aaronson, N.K. (2017)

Article / Letter to editor

• Hormone replacement therapy
• Ovariectomy
• Ovarian carcinoma
• Cancer screening
• BRCA
• Menopause
• Risk-reducing salpingo-oophorectomy

• All authors: Vermeulen, R.F.M.; Beurden, M. van; Kieffer, J.M.; Bleiker, E.M.A.; Valdimarsdottir, H.B.; Massuger, L.F.A.G.; Mourits, M.J.E.; Gaarenstroom, K.N.; Dorst, E.B.L. van; Putten, H.W.H.M. van der; Aaronson, N.K.
• Date: 2017-10-31
• Journal: European Journal of Cancer
• Volume: 84
• Pages: 159 - 167
• DOI: doi:10.1016/j.ejca.2017.07.018